» Articles » PMID: 29346376

Evaluating the Sustainability, Scalability, and Replicability of an STH Transmission Interruption Intervention: The DeWorm3 Implementation Science Protocol

Abstract

Hybrid trials that include both clinical and implementation science outcomes are increasingly relevant for public health researchers that aim to rapidly translate study findings into evidence-based practice. The DeWorm3 Project is a series of hybrid trials testing the feasibility of interrupting the transmission of soil transmitted helminths (STH), while conducting implementation science research that contextualizes clinical research findings and provides guidance on opportunities to optimize delivery of STH interventions. The purpose of DeWorm3 implementation science studies is to ensure rapid and efficient translation of evidence into practice. DeWorm3 will use stakeholder mapping to identify individuals who influence or are influenced by school-based or community-wide mass drug administration (MDA) for STH and to evaluate network dynamics that may affect study outcomes and future policy development. Individual interviews and focus groups will generate the qualitative data needed to identify factors that shape, contextualize, and explain DeWorm3 trial outputs and outcomes. Structural readiness surveys will be used to evaluate the factors that drive health system readiness to implement novel interventions, such as community-wide MDA for STH, in order to target change management activities and identify opportunities for sustaining or scaling the intervention. Process mapping will be used to understand what aspects of the intervention are adaptable across heterogeneous implementation settings and to identify contextually-relevant modifiable bottlenecks that may be addressed to improve the intervention delivery process and to achieve intervention outputs. Lastly, intervention costs and incremental cost-effectiveness will be evaluated to compare the efficiency of community-wide MDA to standard-of-care targeted MDA both over the duration of the trial and over a longer elimination time horizon.

Citing Articles

Coverage of community-wide mass drug administration platforms for soil-transmitted helminths in Benin, India, and Malawi: findings from the DeWorm3 project.

Means A, Asbjornsdottir K, Sharrock K, Galagan S, Aruldas K, Avokpaho E Infect Dis Poverty. 2024; 13(1):72.

PMID: 39380086 PMC: 11460046. DOI: 10.1186/s40249-024-01241-0.


Disability in childhood and the equity of health services: a cross-sectional comparison of mass drug administration strategies for soil-transmitted helminths in southern Malawi.

Witek-McManus S, Simwanza J, Msiska R, Mangawah H, Oswald W, Timothy J BMJ Open. 2024; 14(9):e083321.

PMID: 39242171 PMC: 11381638. DOI: 10.1136/bmjopen-2023-083321.


Serological diagnosis of soil-transmitted helminth (Ascaris, Trichuris and hookworm) infections: A scoping review.

Roose S, Vande Velde F, Vlaminck J, Geldhof P, Levecke B PLoS Negl Trop Dis. 2024; 18(4):e0012049.

PMID: 38574166 PMC: 10994556. DOI: 10.1371/journal.pntd.0012049.


Adolescents' Perspective Regarding a Community-Wide Mass Drug Administration Program for Soil-Transmitted Helminths in India.

Aruldas K, Johnson J, Saxena M, Titus A, Roll A, Ramesh R Am J Trop Med Hyg. 2024; 110(4):681-686.

PMID: 38471161 PMC: 10993849. DOI: 10.4269/ajtmh.23-0676.


"Our desire is to make this village intestinal worm free": Identifying determinants of high coverage of community-wide mass drug administration for soil transmitted helminths in Benin, India, and Malawi.

Saxena M, Roll A, Walson J, Pearman E, Legge H, Nindi P PLoS Negl Trop Dis. 2024; 18(2):e0011819.

PMID: 38319937 PMC: 10846705. DOI: 10.1371/journal.pntd.0011819.


References
1.
Helfrich C, Li Y, Sharp N, Sales A . Organizational readiness to change assessment (ORCA): development of an instrument based on the Promoting Action on Research in Health Services (PARIHS) framework. Implement Sci. 2009; 4:38. PMC: 2716295. DOI: 10.1186/1748-5908-4-38. View

2.
Kirk M, Kelley C, Yankey N, Birken S, Abadie B, Damschroder L . A systematic review of the use of the Consolidated Framework for Implementation Research. Implement Sci. 2016; 11:72. PMC: 4869309. DOI: 10.1186/s13012-016-0437-z. View

3.
Blanchet K, James P . How to do (or not to do) ... a social network analysis in health systems research. Health Policy Plan. 2011; 27(5):438-46. DOI: 10.1093/heapol/czr055. View

4.
Gimbel S, Rustagi A, Robinson J, Kouyate S, Coutinho J, Nduati R . Evaluation of a Systems Analysis and Improvement Approach to Optimize Prevention of Mother-To-Child Transmission of HIV Using the Consolidated Framework for Implementation Research. J Acquir Immune Defic Syndr. 2016; 72 Suppl 2:S108-16. PMC: 5113237. DOI: 10.1097/QAI.0000000000001055. View

5.
Curran G, Bauer M, Mittman B, Pyne J, Stetler C . Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012; 50(3):217-26. PMC: 3731143. DOI: 10.1097/MLR.0b013e3182408812. View